PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO), the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and HIV, today announced that it has strengthened its Management Board with the appointment of Pierre MORGON as Chief Operating Officer (COO).
